FindTrial
Sign In

Efficacy of narrow-band imaging as an additional tool in carcinoma urinary bladder

To evaluate the efficacy of Narrow Band Imaging in the detection of additional malignant lesions after Endoscopic Therapy of Transitional Cell Carcinoma of Urinary Bladder â?? A Prospective, Interventional Study.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/05/024988
Enrollment
57
Registered
2020-05-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C679- Malignant neoplasm of bladder, unspecified

Interventions

Intervention1: Narrow Band Imaging: After endoscopic therapy under white light, switch-over done to Narrow Band Imaging and additional lesions if visualized were resected and sent separately for histo

Sponsors

AIIMS Bhubaneswar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients clinically diagnosed as Carcinoma Bladder and undergoing Endoscopic Therapy

Exclusion criteria

Exclusion criteria: a) Active Urinary Tract Infection b) Gross hematuria that interferes with cystoscopy during Endoscopic therapy c) Bleeding diathesis d) Benign tumor e) High volume tumor not completely resected with Endoscopic therapy f) Muscle-invasive tumors g) Those receiving Chemotherapy or Radiotherapy h) Non-urothelial carcinoma

Design outcomes

Primary

MeasureTime frame
1) To find the efficacy of detection of additional malignant lesions by Narrow Band Imaging after Endoscopic Therapy of Transitional Cell Carcinoma of Urinary Bladder under White Light 2) To catalogue visual characteristics that predict malignancy using Narrow Band ImagingTimepoint: Approximately 10 days from the day of surgery (until the histopathology report is available)—

Secondary

MeasureTime frame
To observe for recurrence after using Narrow Band Imaging after Endoscopic Therapy of Transitional Cell Carcinoma of Urinary BladderTimepoint: 1 year follow up from the day of surgery—

Countries

India

Contacts

Public ContactAnkit Misra

AIIMS Bhubaneswar

prasantnyk@gmail.com9494697071

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026